First National Bank Of Hutchinson Novo Nordisk A S Transaction History

First National Bank Of Hutchinson

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$122.71 - $146.91 $64,054 - $76,687	-522 Reduced 17.15%	2,522 $359,000
Q1 2024 May 08, 2024	BUY	$102.11 - $135.92 $5,309 - $7,067	52 Added 1.74%	3,044 $390,000
Q4 2023 Jan 25, 2024	SELL	$87.78 - $105.45 $79,002 - $94,905	-900 Reduced 23.12%	2,992 $309,000
Q3 2023 Oct 27, 2023	BUY	$90.94 - $199.54 $178,606 - $391,896	1,964 Added 101.87%	3,892 $353,000
Q2 2023 Jul 27, 2023	BUY	$155.98 - $172.65 $4,991 - $5,524	32 Added 1.69%	1,928 $312,000
Q1 2023 Apr 25, 2023	SELL	$132.34 - $159.14 $128,766 - $154,843	-973 Reduced 33.91%	1,896 $301,000
Q3 2022 Oct 21, 2022	BUY	$95.28 - $116.93 $7,717 - $9,471	81 Added 2.91%	2,869 $286,000
Q2 2022 Jul 26, 2022	BUY	$103.24 - $121.81 $1,032 - $1,218	10 Added 0.36%	2,788 $311,000
Q1 2022 Apr 22, 2022	BUY	$93.1 - $112.54 $1,862 - $2,250	20 Added 0.73%	2,778 $308,000
Q4 2021 Feb 09, 2022	BUY	$95.88 - $117.08 $8,245 - $10,068	86 Added 3.22%	2,758 $309,000
Q2 2021 Jul 27, 2021	BUY	$67.66 - $84.76 $180,787 - $226,478	2,672 New	2,672 $224,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of First National Bank Of Hutchinson, based on Form 13F filings with the SEC.

Stay updated on First National Bank Of Hutchinson with notifications on news.